Meta-iodobenzylguanidine (MIBG) is a guanidine analogue of the neurotransmitter norepinephrine. Radioiodinated [ 131I]MIBG is clinically used as a tumor-targeted radiopharmaceutical in the diagnosis and treatment of adrenergic tumors. Moreover, non-radiolabelled MIBG exerts several cell-biological effects...
During the period 1984-90, meta-iodobenzylguanidine (MIBG) scans were performed in 23 patients with suspected phaeochromocytoma seen at the Hammersmith Hospital. Sixteen patients had a histologically proven phaeochromocytoma and in 14 of these patients the tumour was demonstrated by abnormal uptake...
131I-Meta-iodobenzylguanidine in the Management of Metastatic Midgut Carcinoid Tumors The management of metastatic neuroendocrine tumors incorporates multimodal therapy with surgery, biotherapy, and chemotherapy. Tumor-targeted therapies usi... MS Sywak,JL Pasieka,A Mcewan,... - 《World Journal of Surg...
原料品名 META-IODOBENZYLGUANIDINE SULFATE (MIBG-S) 美国DMF登记 暂无权限 供应商信息 企业名称 CIS US INC 备注 若未能联系上供应商,可在药智通发布求购信息(https://s.yaozh.com/Purchase/release),或联系药智通客服17318480790(微信同号) 扩展信息 ...
Aim: To evaluate the reliability of [123I]meta-iodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease (PD). Patie... H,Nagayama,M,... - 《Journal of Neurology Neurosurgery & Psychiatry》 被引量: 169发表: 2005年 Limited role of meta-iodobenzylguanidine scintigrap...
Targeted radiotherapy using radiolabelled meta-iodobenzylguanidine (MIBG) is a promising treatment option for bladder cancer, restricting the effects of radiotherapy to malignant cells thereby increasing efficacy and decreasing morbidity of radiotherapy. We investigated the efficacy of a combined gene therapy...
I]meta-iodobenzylguanidine ([I]MIBG) is the most commonly used treatment for metastatic pheochromocytoma and paraganglioma. It enters the chromaffin cells ... L Martiniova,SM Perera,FM Brouwers,... - 《Endocr Relat Cancer》 被引量: 42发表: 2011年 Treatment of Metastatic Pheochromocytoma and ...